Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Burning Rock Biotech Limited

Market Cap 580M 85.74M 73.89M 68.04M 63.89M 120M 8.11B 121M 804M 313M 3.97B 322M 315M 13.76B P/E Ratio 2024
-1.46x
P/E Ratio 2025 -27.1x
Enterprise Value 142M 21M 18.1M 16.66M 15.65M 29.37M 1.99B 29.68M 197M 76.71M 972M 78.8M 77.13M 3.37B EV / Sales 2024
0.06x
EV / Sales 2025 2x
Free-Float
61.34%
Yield 2024 *
-
Yield 2025 -
1 day-7.19%
1 week-0.61%
Current month-12.77%
1 month-52.29%
3 months-52.15%
6 months-56.62%
Current year-59.65%
1 week 8.12
Extreme 8.12
10
1 month 8.12
Extreme 8.12
18.3
Current year 8.12
Extreme 8.12
41.72
1 year 3.06
Extreme 3.06
41.72
3 years 2.18
Extreme 2.18
41.72
5 years 2.18
Extreme 2.18
305
10 years 2.18
Extreme 2.18
397.5
Manager TitleAgeSince
Corporate Officer/Principal - 2013-12-31
Chief Executive Officer 48 2013-12-31
Director of Finance/CFO - 2024-09-26
Director TitleAgeSince
Chairman 48 -
Director/Board Member 55 2014-05-31
Director/Board Member 63 2016-07-31
Date Insider Type Main position Quantity % Market Cap.
03-30Buy

Chief Executive Officer

314,870 0.3584%
03-17
Northern Light Venture Capital Development Ltd.
OtherCompany 11,880,245 13.5213%
03-16Other

Chief Financial Officer

146,214 0.1664%
Change 5-day change 1-year change 3-year change Capi.($)
-7.19%-0.61%+140.18%-67.48% 85.74M
+0.15%+1.47%+14.77%+4.09% 9.25B
-2.04%-1.86% - - 1.32B
-0.61%-0.49%+10.09%-12.71% 1.22B
+1.47%+0.23%-10.69%-28.04% 951M
-0.16%-0.33%+80.65%+46.80% 715M
-0.56%-2.63%-14.12% - 613M
+3.49%+5.78%+114.68%+168.08% 402M
-0.14%-1.97%-14.05%-13.02% 378M
+1.32%+14.98%-61.24%-84.13% 235M
Average -0.43%+2.96%+28.92%+1.70% 1.52B
Weighted average by Cap. -0.00%+1.63%+16.33%+5.01%

Financials

2024 2025
Net sales 516M 76.31M 65.76M 60.55M 56.85M 107M 7.21B 108M 716M 279M 3.53B 286M 280M 12.24B 540M 79.82M 68.79M 63.34M 59.47M 112M 7.55B 113M 748M 292M 3.7B 300M 293M 12.81B
Net income -347M -51.28M -44.19M -40.69M -38.21M -71.73M -4.85B -72.49M -481M -187M -2.37B -192M -188M -8.23B -55.35M -8.19M -7.06M -6.5M -6.1M -11.45M -774M -11.57M -76.78M -29.91M -379M -30.73M -30.07M -1.31B
Net Debt -474M -70.07M -60.39M -55.61M -52.21M -98.02M -6.62B -99.06M -657M -256M -3.24B -263M -257M -11.24B -438M -64.74M -55.8M -51.38M -48.24M -90.57M -6.12B -91.53M -607M -237M -3B -243M -238M -10.39B
Logo Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a Company principally engaged in developing and providing cancer therapy selection tests. The Company operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Employees
667
Date Price Change Volume
26-06-16 8.130 $ -7.19% 32,199
26-06-15 8.760 $ +1.98% 14,125
26-06-12 8.590 $ -2.72% 48,273
26-06-11 8.830 $ +6.00% 18,584
26-06-10 8.330 $ +1.83% 9,534
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!